Date: October 6-7, 2020
Location: London, United Kingdom

We have seen a dramatic improvement of medical care in recent decades, which led to a higher quality of life both for patients and their relatives. However, biopharma companies admit there is a lot to be made with regard to the clinical trial, mainly in terms of high costs, patient recruitment and engagement, quality of data, protocols and other archaic procedures. It looks like current way of conducting trials is…